| scholarly article | Q13442814 |
| P50 | author | José Eduardo Krieger | Q37370842 |
| P2093 | author name string | Scott Smemo | |
| Alexandre C Pereira | |||
| Marcelo A Nobrega | |||
| Ivan P Moskowitz | |||
| Luciene C Campos | |||
| P2860 | cites work | Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project | Q21061203 |
| A user's guide to the encyclopedia of DNA elements (ENCODE) | Q21092716 | ||
| Genomic views of distant-acting enhancers | Q22122210 | ||
| A global control region defines a chromosomal regulatory landscape containing the HoxD cluster | Q24301317 | ||
| GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5 | Q24307366 | ||
| Congenital heart disease caused by mutations in the transcription factor NKX2-5 | Q24311343 | ||
| Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family | Q24311501 | ||
| Mutations in human TBX5 [corrected] cause limb and cardiac malformation in Holt-Oram syndrome | Q24311600 | ||
| A loss-of-function mutation in the binding domain of HAND1 predicts hypoplasia of the human hearts | Q24314253 | ||
| Mutations in cardiac T-box factor gene TBX20 are associated with diverse cardiac pathologies, including defects of septation and valvulogenesis and cardiomyopathy | Q24324422 | ||
| TRANSFAC: a database on transcription factors and their DNA binding sites | Q24545748 | ||
| ECR Browser: a tool for visualizing and accessing data from comparisons of multiple vertebrate genomes | Q24562130 | ||
| Targeted capture and massively parallel sequencing of 12 human exomes | Q24615381 | ||
| A map of human genome variation from population-scale sequencing | Q24617794 | ||
| Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome | Q24622470 | ||
| From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus | Q24633183 | ||
| Tbx20 regulates a genetic program essential to adult mouse cardiomyocyte function | Q24634382 | ||
| The colorectal cancer risk at 18q21 is caused by a novel variant altering SMAD7 expression | Q24647961 | ||
| Early endocardial morphogenesis requires Scl/Tal1 | Q27314921 | ||
| Stages of embryonic development of the zebrafish | Q27860947 | ||
| A long-range Shh enhancer regulates expression in the developing limb and fin and is associated with preaxial polydactyly | Q28184095 | ||
| Familial heart disease with skeletal malformations | Q28202984 | ||
| ChIP-Seq identification of weakly conserved heart enhancers | Q28291198 | ||
| Cell movements during epiboly and gastrulation in zebrafish | Q28294886 | ||
| Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease | Q28301461 | ||
| Tbx5-dependent rheostatic control of cardiac gene expression and morphogenesis | Q28510707 | ||
| Tbx3 is required for outflow tract development | Q28590164 | ||
| A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease | Q28594121 | ||
| Aligning multiple genomic sequences with the threaded blockset aligner | Q29547490 | ||
| VISTA: computational tools for comparative genomics | Q29547708 | ||
| The incidence of congenital heart disease | Q29614195 | ||
| Exome sequencing as a tool for Mendelian disease gene discovery | Q29615382 | ||
| Detection of messenger RNA by in situ hybridization to tissue sections and whole mounts | Q29618776 | ||
| Detection of nonneutral substitution rates on mammalian phylogenies | Q30080028 | ||
| rVISTA 2.0: evolutionary analysis of transcription factor binding sites | Q31081582 | ||
| Genome-wide discovery of human heart enhancers | Q33523952 | ||
| Allelic variation at the 8q23.3 colorectal cancer risk locus functions as a cis-acting regulator of EIF3H. | Q33700619 | ||
| Genome-wide association study of PR interval | Q33772170 | ||
| An 8q24 gene desert variant associated with prostate cancer risk confers differential in vivo activity to a MYC enhancer | Q34085123 | ||
| Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction | Q34149773 | ||
| In vivo characterization of a vertebrate ultraconserved enhancer | Q34417560 | ||
| Co-occupancy by multiple cardiac transcription factors identifies transcriptional enhancers active in heart. | Q34805195 | ||
| Alterations in TCF7L2 expression define its role as a key regulator of glucose metabolism | Q35195941 | ||
| Visualization and functional characterization of the developing murine cardiac conduction system | Q36778773 | ||
| The developmental genetics of congenital heart disease. | Q37089736 | ||
| 9p21 DNA variants associated with coronary artery disease impair interferon-γ signalling response | Q39048288 | ||
| Deletions and microdeletions of 22q11.2 in velo-cardio-facial syndrome | Q41091241 | ||
| Transcriptional enhancers in development and disease | Q41901525 | ||
| Loss of Cited2 causes congenital heart disease by perturbing left-right patterning of the body axis | Q43966599 | ||
| The heartstrings mutation in zebrafish causes heart/fin Tbx5 deficiency syndrome. | Q44132465 | ||
| The development of the septum primum relative to atrial septation in the mouse heart | Q44406790 | ||
| Chamber-specific cardiac expression of Tbx5 and heart defects in Holt-Oram syndrome | Q47955346 | ||
| Tbx5 is essential for heart development | Q47980164 | ||
| Identification and characterisation of the developmental expression pattern of tbx5b, a novel tbx5 gene in zebrafish. | Q51922238 | ||
| lyl-1 and tal-1/scl, two genes encoding closely related bHLH transcription factors, display highly overlapping expression patterns during cardiovascular and hematopoietic ontogeny. | Q52001531 | ||
| Ventricular expression of tbx5 inhibits normal heart chamber development. | Q52167439 | ||
| Vasculogenesis in the day 6.5 to 9.5 mouse embryo. | Q52170686 | ||
| An SCL 3' enhancer targets developing endothelium together with embryonic and adult haematopoietic progenitors. | Q52175329 | ||
| Several common variants modulate heart rate, PR interval and QRS duration | Q57309310 | ||
| The 14q22.2 colorectal cancer variant rs4444235 shows cis-acting regulation of BMP4 | Q57319561 | ||
| Tbx5 and Tbx4 trigger limb initiation through activation of the Wnt/Fgf signaling cascade | Q60362573 | ||
| The olfactory placodes of the zebrafish form by convergence of cellular fields at the edge of the neural plate | Q74139041 | ||
| P433 | issue | 14 | |
| P921 | main subject | congenital disorder | Q727096 |
| P304 | page(s) | 3255-3263 | |
| P577 | publication date | 2012-04-27 | |
| P1433 | published in | Human Molecular Genetics | Q2720965 |
| P1476 | title | Regulatory variation in a TBX5 enhancer leads to isolated congenital heart disease | |
| P478 | volume | 21 |
| Q41126903 | A TBX5 3'UTR variant increases the risk of congenital heart disease in the Han Chinese population |
| Q59812119 | A novel de novo mutation in a patient with Holt-Oram syndrome |
| Q56807545 | A promoter interaction map for cardiovascular disease genetics |
| Q38915433 | Allele-specific transcriptional regulation of IRF4 in melanocytes is mediated by chromatin looping of the intronic rs12203592 enhancer to the IRF4 promoter |
| Q38149683 | Application of high-throughput sequencing for studying genomic variations in congenital heart disease |
| Q37560668 | Association of promoter methylation statuses of congenital heart defect candidate genes with Tetralogy of Fallot |
| Q66678776 | Beyond the Exome: The Non-coding Genome and Enhancers in Neurodevelopmental Disorders and Malformations of Cortical Development |
| Q38205413 | Cis-regulatory variation: significance in biomedicine and evolution |
| Q38940534 | Common Variants Confer Susceptibility to Barrett's Esophagus: Insights from the First Genome-Wide Association Studies |
| Q33790650 | Complex genetics and the etiology of human congenital heart disease |
| Q35983745 | De Novo and Rare Variants at Multiple Loci Support the Oligogenic Origins of Atrioventricular Septal Heart Defects. |
| Q33639681 | Decoding the complex genetic causes of heart diseases using systems biology |
| Q38185270 | Disruption of long-range gene regulation in human genetic disease: a kaleidoscope of general principles, diverse mechanisms and unique phenotypic consequences |
| Q36404968 | Early cardiac development: a view from stem cells to embryos |
| Q92435023 | Emerging role of long non-coding RNAs in normal and malignant hematopoiesis |
| Q34624854 | Enhancer alterations in cancer: a source for a cell identity crisis |
| Q50700523 | Enhancer mutations and phenotype modularity. |
| Q92675134 | Enhancer-gene maps in the human and zebrafish genomes using evolutionary linkage conservation |
| Q35097959 | Enhancers compete with a long non-coding RNA for regulation of the Kcnq1 domain |
| Q88568711 | Enhancers: bridging the gap between gene control and human disease |
| Q22121999 | Enhancers: five essential questions |
| Q57799456 | Evolutionarily conserved - pathway orchestrates cardiopulmonary development |
| Q59807135 | Expanded Insights Into Mechanisms of Gene Expression and Disease Related Disruptions |
| Q41813578 | Functional characterization of tissue-specific enhancers in the DLX5/6 locus |
| Q47652668 | Functional role of PLCE1 intronic insertion variant associated with susceptibility to esophageal squamous-cell carcinoma. |
| Q90669133 | Genetic Basis for Congenital Heart Disease: Revisited: A Scientific Statement From the American Heart Association |
| Q35825203 | Genetic Variation Determines PPARγ Function and Anti-diabetic Drug Response In Vivo. |
| Q38568437 | Genetic, environmental, and epigenetic factors involved in CAKUT. |
| Q30235241 | Genetics and Genomics of Congenital Heart Disease |
| Q38556981 | Genetics of congenital heart disease: the contribution of the noncoding regulatory genome. |
| Q39141707 | High-Throughput Assays to Assess the Functional Impact of Genetic Variants: A Road Towards Genomic-Driven Medicine. |
| Q34576306 | Holt Oram syndrome: a registry-based study in Europe |
| Q90527320 | Holt-Oram syndrome: clinical and molecular description of 78 patients with TBX5 variants |
| Q92666060 | Identification of a 42-bp heart-specific enhancer of the notch1b gene in zebrafish embryos |
| Q58193248 | Identification ofTBX5mutations in a series of 94 patients with Tetralogy of Fallot |
| Q60930390 | Important cardiac transcription factor genes are accompanied by bidirectional long non-coding RNAs |
| Q90929709 | Influence of genetic polymorphism on transcriptional enhancer activity in the malaria vector Anopheles coluzzii |
| Q37645318 | Inhibition of Gata4 and Tbx5 by Nicotine-Mediated DNA Methylation in Myocardial Differentiation |
| Q40388296 | Long-range evolutionary constraints reveal cis-regulatory interactions on the human X chromosome |
| Q38880251 | Looking beyond the genes: the role of non-coding variants in human disease |
| Q37642709 | MIAT Is a Pro-fibrotic Long Non-coding RNA Governing Cardiac Fibrosis in Post-infarct Myocardium |
| Q34505492 | MicroRNA 218 mediates the effects of Tbx5a over-expression on zebrafish heart development |
| Q38259339 | Morphogenesis and molecular considerations on congenital cardiac septal defects |
| Q37375825 | Mutations in the noncoding genome |
| Q38202142 | Next-generation sequencing applied to rare diseases genomics |
| Q28236283 | Obesity-associated variants within FTO form long-range functional connections with IRX3 |
| Q55221664 | Prediction of enhancer-promoter interactions via natural language processing. |
| Q37137902 | Probing chromatin landscape reveals roles of endocardial TBX20 in septation. |
| Q33728420 | Recent advances in understanding the genetics of congenital heart defects |
| Q34040436 | Recessive mutations in a distal PTF1A enhancer cause isolated pancreatic agenesis. |
| Q28595944 | Regulatory evolution of Tbx5 and the origin of paired appendages |
| Q36464706 | Single nucleotide polymorphism of NKX2-5 gene with sporadic congenital heart disease in Chinese Bai population |
| Q35808773 | Single-Cell Expression Profiling Reveals a Dynamic State of Cardiac Precursor Cells in the Early Mouse Embryo |
| Q38920721 | Spatiotemporal regulation of enhancers during cardiogenesis |
| Q37685234 | T-box family of transcription factor-TBX5, insights in development and disease |
| Q39068859 | TBX5: A Key Regulator of Heart Development. |
| Q35697680 | Tetralogy of Fallot and Hypoplastic Left Heart Syndrome - Complex Clinical Phenotypes Meet Complex Genetic Networks |
| Q92810976 | The clinical and genetic characteristics of permanent neonatal diabetes (PNDM) in the state of Qatar |
| Q41620441 | The role of histone modification and a regulatory single-nucleotide polymorphism (rs2071166) in the Cx43 promoter in patients with TOF. |
| Q28067751 | Transcriptional Dynamics at Brain Enhancers: from Functional Specialization to Neurodegeneration |
| Q90741845 | Transcriptional Programs and Regeneration Enhancers Underlying Heart Regeneration |
| Q26782507 | Transcriptional enhancers: functional insights and role in human disease |
| Q26851780 | Variation in vertebrate cis-regulatory elements in evolution and disease |
| Q26770160 | View from the heart: cardiac fibroblasts in development, scarring and regeneration |
Search more.